REFG Medical Cannabis Payment Solutions (CE)

Medical Cannabis Payment Solutions (OTC Markets: REFG) (www.refg.co), issued a statement today supporting the U.S. Food and Drug Administration’s (FDA) decision to grant orphan drug designation for a cannabis extract for use in children with a severe form of epilepsy called Dravet syndrome. The product contains plant-derived Cannabidiol, a non-psychoactive molecule from the cannabis plant.

Jeremy Roberts, CEO of Medical Cannabis Payment Solutions, said: "As a leading proponent of the safe and proper use of legal medical marijuana, it has long been our position that we’re just beginning to see the public health benefits of this amazing herb.”

The company reiterated its position to work with policymakers to form compassionate, data-based regulations.

Mr. Roberts continued, “We’re already working with Utah’s state legislature as they explore similar products to treat epilepsy.”

The company will be meeting with Utah legislators at today’s interim legislative session.

About REFG, Inc.

Our mission is to provide end-to-end management, across multiple management systems, for medicinal marijuana operations. Many medicinal marijuana companies have experienced such rapid growth that they are finding it difficult to manage all aspects of their operation. In order to become a successful and compliant medicinal marijuana operation, effective management must depend on many different systems. REFG solves the fragmentation problem by identifying tools that are important to dispensaries, and customizing those tools specifically catered to the industry. We strive to create awareness within the medicinal marijuana industry and to develop an environmentally friendly, economically sustainable business while increasing shareholder value. For more information, please visit the company's website at: www.refg.co.

FORWARD-LOOKING STATEMENT

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of REFG, Inc. to be materially different from the statements made herein.

Jeremy@refg.co

www.refg.co

CorporateREFG, Inc.Jeremy Roberts702-706-7011Jeremy@refg.cowww.refg.co

Medical Cannabis Payment... (CE) (USOTC:REFG)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

Medical Cannabis Payment... (CE) (USOTC:REFG)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024